Seeing Is Believing

Currently out of the existing stock ratings of Carter Gould, 215 are a BUY (54.85%), 148 are a HOLD (37.76%), 29 are a SELL (7.4%).
Analyst Carter Gould, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 73.82% that have a potential upside of 27.13% achieved within 278 days. Previously, Carter Gould worked at BARCLAYS.
Carter Gould’s has documented 779 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Basic Materials, Technology sectors.
Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 08-Oct-2026.
Analyst best performing recommendations are on APLT (APPLIED THERAPEUTICS).
The best stock recommendation documented was for APLT (APPLIED THERAPEUTICS) at 3/21/2022. The price target of $2.5 was fulfilled within 3 days with a profit of $0.67 (36.61%) receiving and performance score of 122.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Feb-2026
$325
$40.2 (14.12%)
$300
Buy Since 04-Feb-2020
$288
$3.2 (1.12%)
$288
13 days ago
(09-Oct-2026)
45/45 (100%)
$11.53 (4.17%)
407
Hold Since 06-Jan-2026
$275
$-9.8 (-3.44%)
$260
13 days ago
(09-Oct-2026)
5/5 (100%)
$-1.47 (-0.53%)
76
Buy Since 16-Oct-2020
$300
$15.2 (5.34%)
$280
14 days ago
(08-Oct-2026)
20/21 (95.24%)
$27.58 (10.12%)
441
Buy Since 15-Nov-2023
$290
$5.2 (1.83%)
$285
14 days ago
(08-Oct-2026)
31/32 (96.88%)
$17.58 (6.45%)
251
Which stock is Carter Gould most bullish on?
Which stock is Carter Gould most reserved on?
What Year was the first public recommendation made by Carter Gould?